SCHEMBL11089992

SCHEMBL11089992

CCCC(C)(CO)CCCCCCCCC(C)(CO)CCC

nearest known ligand 0.35

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
LMNA P02545 3/20 0.35
HSD17B10 Q99714 2/20 0.35
GGPS1 O95749 6/20 0.33
ALDH1A1 P00352 2/20 0.33
MEN1 O00255 1/20 0.33
KMT2A Q03164 1/20 0.33
TSHR P16473 1/20 0.33
CYP4F2 P78329 1/20 0.32
CYP4A11 Q02928 1/20 0.32
FDPS P14324 9/20 0.32
CES2 O00748 1/20 0.31
LPAR1 Q92633 1/20 0.31
LPAR3 Q9UBY5 1/20 0.31
SMPD1 P17405 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11082653 1.00 LMNA (0.35) LMNAHSD17B10GGPS1ALDH1A1MEN1
SCHEMBL11086579 1.00 LMNA (0.35) LMNAHSD17B10GGPS1ALDH1A1MEN1
SCHEMBL9345919 0.93 LMNA (0.46) LMNAHSD17B10GGPS1ALDH1A1MEN1
SCHEMBL20856425 0.92 SMN1; SMN2 (0.39) LMNAHSD17B10GGPS1ALDH1A1MEN1
SCHEMBL20853876 0.92 SMN1; SMN2 (0.39) LMNAHSD17B10GGPS1ALDH1A1MEN1
SCHEMBL20856338 0.90 LMNA (0.46) LMNAHSD17B10GGPS1ALDH1A1MEN1
SCHEMBL20856452 0.90 LMNA (0.46) LMNAHSD17B10GGPS1ALDH1A1MEN1
SCHEMBL20853885 0.90 LMNA (0.46) LMNAHSD17B10GGPS1ALDH1A1MEN1
SCHEMBL20856412 0.90 LMNA (0.46) LMNAHSD17B10GGPS1ALDH1A1MEN1
SCHEMBL20853877 0.90 LMNA (0.46) LMNAHSD17B10GGPS1ALDH1A1MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 59 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4706956-A1 LAMINATION STRUCTURE FOR RETORT APPLICATIONS Siegwerk Druckfarben AG & Co. KGaA (DE) 2026-03-11 EP disclosed
EP-4706954-A1 DEBONDABLE LAMINATION STRUCTURE FOR RETORT APPLICATION Siegwerk Druckfarben AG & Co. KGaA (DE) 2026-03-11 EP disclosed
EP-4705367-A1 LAMINATION ADHESIVE Bostik SA (FR) 2026-03-11 EP disclosed
US-12545823-B2 Lamination adhesive for sterilisation BOSTIK SA (FR) 2026-02-10 US disclosed
US-12516147-B2 Aldimines and uses thereof BOSTIK SA (FR) 2026-01-06 US disclosed
US-20260002061-A1 TWO-COMPONENT COMPOSITION BOSTIK SA (FR) 2026-01-01 US disclosed
EP-3959283-B1 LAMINATION ADHESIVE FOR STERILISATION BOSTIK SA (FR) 2025-10-22 EP disclosed
EP-4561827-A1 RECYCLED ARTICLE AND USES THEREOF Bostik SA (FR) 2025-06-04 EP disclosed
EP-4561826-A1 METHOD FOR RECYCLING A MULTILAYER SYSTEM Bostik SA (FR) 2025-06-04 EP disclosed
EP-4561828-A1 ADHESIVE COMPOSITION Bostik SA (FR) 2025-06-04 EP disclosed
WO-2020217023-A1 LAMINATION ADHESIVE FOR STERILISATION BOSTIK SA (FR) 2020-10-29 WO disclosed
EP-3724291-A1 ADHESIVE MULTICOMPONENT COMPOSITION AND USES THEREOF Bostik SA (FR) 2020-10-21 EP disclosed
US-20200317962-A1 ADHESIVE MULTICOMPONENT COMPOSITION AND USES THEREOF BOSTIK SA (FR) 2020-10-08 US disclosed
CN-111433308-A Multi-component adhesive composition and use thereof 博斯蒂克股份公司 2020-07-17 CN disclosed
EP-3658604-A1 HEAT-CROSSLINKABLE ADHESIVE COMPOSITION Bostik SA (FR) 2020-06-03 EP disclosed
CN-110914325-A Thermally crosslinkable adhesive composition 博斯蒂克股份公司 2020-03-24 CN disclosed
WO-2019115952-A1 ADHESIVE MULTICOMPONENT COMPOSITION AND USES THEREOF BOSTIK SA (FR) 2019-06-20 WO disclosed
WO-2019020943-A1 HEAT-CROSSLINKABLE ADHESIVE COMPOSITION BOSTIK SA (FR) 2019-01-31 WO disclosed
US-4454145-A Nicotinates of alkanediols having hypolipidaemic activity and pharmaceutical compositions containing them ALFA FARMACEUTICI S.P.A. (IT) 1984-06-12 US disclosed
EP-0064286-A2 New derivatives of alkanediols having hypolipidaemic activity, methods for their preparation and pharmaceutical compositions containing them ALFA FARMACEUTICI S.p.A. (IT) 1982-11-10 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12545823-B2 Lamination adhesive for sterilisation C9, CDH1, RCC1 LMNA 179/4885HSD17B10 422/4885GGPS1 1967/4885
US-20260002061-A1 TWO-COMPONENT COMPOSITION SDC2, C9, SDAD1 LMNA 1527/4885HSD17B10 585/4885GGPS1 1724/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.